Your session is about to expire
← Back to Search
Povidone-Iodine for Preventing Staph Infection Before Surgery
Study Summary
This trial will evaluate if a single-dose of 10% povidone-iodine can reduce nasal carriage of S. aureus/MRSA before surgery.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your immune system is weakened.You had a surgery that makes it impossible for doctors to access your nostrils during the study.You are pregnant.
- Group 1: treatment
- Group 2: placebo
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are individuals above the age of 55 being considered for participation in this trial?
"This study is open to any individual who is 18 years of age or older and below the octogenarian mark."
Is it possible for me to participate in this medical research study?
"This study requires 170 individuals aged between 18 and 80 who have experienced surgical wound infection. To be eligible, they must also meet the criteria of outpatient surgery lasting at least one hour but not longer than six hours in duration as well being a community-based patient with an American Society of Anesthesiology (ASA) score from 1 to 3."
Are there any unoccupied positions available in this clinical trial?
"According to clinicaltrials.gov, this research is actively seeking participants; the trial was initially advertised on September 6th 2022 and most recently updated November 9th 2022."
What potential hazards could patients face with this form of treatment?
"Due to this being a Phase 4 trial, and thus the treatment having been approved by medical regulators, we estimate its safety rating on our scale of 1-3 as 3."
How many individuals are being recruited for this clinical experiment?
"Indeed, the protocol listed on clinicaltrials.gov attests to this trial's current recruitment status. The initial posting occurred on September 6th 2022 and was most recently modified November 9th 2022. 170 volunteers are necessary from one site alone."
Share this study with friends
Copy Link
Messenger